Cme (CME) Notes Payables (2009 - 2025)

Cme (CME) has reported Notes Payables for 10 consecutive years, with $750.0 million the latest figure, recorded in Q1 2025.

• Quarterly Notes Payables changed 0.09% year-over-year to $750.0 million in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $750.0 million (changed 0.09% YoY) and the FY2024 annual result came in at $749.8 million, changed N/A from the prior year.
• Notes Payables held at $750.0 million in Q1 2025 per CME's latest filing, from $749.8 million in the prior quarter.
• Over the last five years, Notes Payables for CME reached as high as $750.0 million in Q1 2025 and fell as low as $14.5 million in Q3 2022.
• A 5-year average of $529.4 million and a median of $749.4 million in 2021 frame the typical range for Notes Payables.
• Annual changes were most pronounced in 2022 — Notes Payables plunged 98.06% — and 2024, when it surged 4496.93%.
• Year by year, Notes Payables stood at $749.4 million in 2021, then tumbled by 97.86% to $16.0 million in 2022, then climbed by 1.88% to $16.3 million in 2023, then jumped by 4500.0% to $749.8 million in 2024, then rose by 0.03% to $750.0 million in 2025.
• According to Business Quant data, Notes Payables over the past three periods registered $750.0 million, $749.8 million, and $749.7 million for Q1 2025, Q4 2024, and Q3 2024 respectively.